A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkad1099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Johanna Jönsson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry and Microbiology, Uppsala University, BMC-B9, 751 23 Uppsala, Sweden. Hauptthemen laut MEDLINE: Human papillomavirus 16, Oncogene Proteins, Viral, Repressor Proteins, Keratinocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swedish Research Council, Swedish Cancer Society, Stiftelsen Clas Groschinskys Minnesfond.
Abstract (Originalsprache)
High-risk carcinogenic human papillomaviruses (HPVs), e.g. HPV16, express the E6 and E7 oncogenes from two mRNAs that are generated in a mutually exclusive manner by splicing. The HPV16 E7 mRNA, also known as the E6*I/E7 mRNA, is produced by splicing between splice sites SD226 and SA409, while E6 mRNAs retain the intron between these splice sites. We show that splicing between HPV16 splice sites SD226 and SA409 is controlled by a splicing enhancer consisting of a perfect repeat of an adenosine-rich, 11 nucleotide sequence: AAAAGCAAAGA. Two nucleotide substitutions in both 11 nucleotide sequences specifically inhibited production of the spliced E6*I/E7 mRNA. As a result, production of E7 protein was reduced and the ability of HPV16 to immortalize human primary keratinocytes was abolished. The splicing-enhancing effect was mediated by the cellular TRAP150/THRAP3 protein that also enhanced splicing of other high-risk HPV E6*I/E7 mRNAs, but had no effect on low-risk HPV mRNAs. In summary, we have identified a novel splicing enhancer in the E6 coding region that is specific for high-risk HPVs and that is critically linked to HPV16 carcinogenic properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry and Microbiology, Uppsala University, BMC-B9, 751 23 Uppsala, Sweden.
- Center of Translational Medicine, Zibo Central Hospital, 255036 Zibo, China.
ORCID-Profile: Naoko Kajitani, Stefan Schwartz
Förderung
- Swedish Research Council
- Swedish Cancer Society
- Stiftelsen Clas Groschinskys Minnesfond
Zitieren
APA
Jönsson, J., Wang, L., Kajitani, N., & Schwartz, S. (2024). A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad1099
Vancouver
Jönsson J, Wang L, Kajitani N, Schwartz S. A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization. Nucleic Acids Research. 2024. doi:10.1093/nar/gkad1099
BibTeX
@article{Jnsson2024,
author = {Jönsson, Johanna and Wang, Lianqing and Kajitani, Naoko and Schwartz, Stefan},
title = {A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkad1099}
}
EUVIMED